{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:31:12Z","timestamp":1792816272248,"version":"4.5.0"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Kidney disease is one of the leading non-communicable diseases related to tremendous health and economic burden globally. Diabetes, hypertension, obesity and cardiovascular conditions are the major risk factors for kidney disease, followed by infections, toxicity and autoimmune causes. The peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) is a ligand-activated nuclear receptor that plays an essential role in kidney physiology and disease. The synthetic agonists of PPAR-\u03b3 shows a therapeutic effect in various kidney conditions; however, the associated side effect restricts their use. Therefore, there is an increasing interest in exploring natural products with PPAR\u03b3-activating potential, which can be a promising solution to developing effective and safe treatment of kidney diseases. In this review, we have discussed the role of PPAR-\u03b3 in the pathophysiology of kidney disease and the potential of natural PPAR-\u03b3 agonists in treating various kidney diseases, including acute kidney injury, diabetic kidney disease, obesity-induced nephropathy, hypertension nephropathy and IgA nephropathy. PPAR-\u03b3 is a potential target for the natural PPAR-\u03b3 agonists against kidney disease; however, more studies are required in this direction.<\/jats:p>","DOI":"10.3389\/fphar.2022.991059","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T06:33:06Z","timestamp":1666333986000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Vinesh","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Patial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cardiores.2004.12.008","article-title":"Beneficial effects of PPAR-\u03b3 ligands in ischemia\u2013reperfusion injury, inflammation and shock","volume":"65","author":"Abdelrahman","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-783X-18-12","article-title":"Leptin, resistin and visfatin: The missing link between endocrine metabolic disorders and immunity","volume":"18","author":"Al-Suhaimi","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"R542","DOI":"10.1152\/ajpregu.00200.2013","article-title":"Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats","volume":"305","author":"Beaudoin","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"Benson","year":"2004","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"28282","DOI":"10.1038\/srep28282","article-title":"The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial","volume":"6","author":"Borges","year":"2016","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/jn\/138.9.1677","article-title":"The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice","volume":"138","author":"Bose","year":"2008","journal-title":"J. Nutr. ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jep.2010.06.004","article-title":"Zhen-Wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats","volume":"131","author":"Cai","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/ijms17071069","article-title":"The effect of resveratrol and quercetin treatment on PPAR mediated uncoupling protein (UCP-) 1, 2, and 3 expression in visceral white adipose tissue from metabolic syndrome rats","volume":"17","author":"Castrej\u00f3n-Tellez","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/0886022X.2010.523486","article-title":"IgA nephropathy in India: What we do know","volume":"33","author":"Chacko","year":"2011","journal-title":"Ren. Fail."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.3390\/ijms19072063","article-title":"Maintenance of kidney metabolic homeostasis by PPAR gamma","volume":"19","author":"Corrales","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.pharmtox.40.1.491","article-title":"Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators","volume":"40","author":"Corton","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"409168","DOI":"10.1155\/2010\/409168","article-title":"PPARG: Gene expression regulation and next-generation sequencing for unsolved issues","volume":"10","author":"Costa","year":"2010","journal-title":"PPAR Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"549691","DOI":"10.1155\/2015\/549691","article-title":"PPAR\u03b3 and the innate immune system mediate the resolution of inflammation","volume":"2015","author":"Croasdell","year":"2015","journal-title":"PPAR Res."},{"key":"B15","volume-title":"FDA reaffirms bladder cancer risk with Use of pioglitazone","author":"Dangi-Garimella","year":"2016"},{"key":"B16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.biopha.2018.01.036","article-title":"Upregulation of PPAR-\u03b3 mediates the renoprotective effect of omega-3 PUFA and ferulic acid in gentamicin-intoxicated rats","volume":"99","author":"El-Ashmawy","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494694","article-title":"Underlying mechanisms of renal lipotoxicity in obesity","volume":"143","author":"Escasany","year":"2019","journal-title":"Nephron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/mnfr.200900119","article-title":"Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors","volume":"54","author":"Fang","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2337\/dc12-1503","article-title":"Renal glucose handling: Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes","volume":"36","author":"Ferrannini","year":"2013","journal-title":"Diabetes care"},{"key":"B20","article-title":"Physiology, renin angiotensin system","volume-title":"StatPearls [Internet]","author":"Fountain","year":"2017"},{"key":"B21","first-page":"49","article-title":"Diabetic kidney disease: World-wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2016","journal-title":"J. Nephropharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","article-title":"Lipolysis: Cellular mechanisms for lipid mobilization from fat stores","volume":"3","author":"Grabner","year":"2021","journal-title":"Nat. Metab."},{"key":"B23","volume-title":"Conjugated linoleic acid in the treatment of murine autoimmune glomerulonephritis (Doctoral dissertation","author":"Hammond","year":"2015"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1039\/c3fo60575b","article-title":"A novel PPARgamma agonist monascin's potential application in diabetes prevention","volume":"5","author":"Hsu","year":"2014","journal-title":"Food Funct."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfm021","article-title":"Troglitazone hepatotoxicity: Are we getting closer to understanding idiosyncratic liver injury?","volume":"97","author":"Jaeschke","year":"2007","journal-title":"Toxicol. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.3390\/molecules14103922","article-title":"Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban","volume":"14","author":"James","year":"2009","journal-title":"Molecules"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2Fs40064-016-3364-1","article-title":"Multivariate analysis and molecular interaction of curcumin with PPAR\u03b3 in high fructose diet induced insulin resistance in rats","volume":"5","author":"Jayakumar","year":"2016","journal-title":"Springer plus"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.ki.5002248","article-title":"PPAR-\u03b3 agonist protects podocytes from injury","volume":"71","author":"Kanjanabuch","year":"2007","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.3748\/wjg.v28.i28.3535","article-title":"Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios","volume":"28","author":"Katoch","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"183108","DOI":"10.1155\/2008\/183108","article-title":"PPAR in kidney physiology and pathophysiology","volume":"2008","author":"Kiss-T\u00f3th","year":"2009","journal-title":"PPAR Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/db10-0386","article-title":"Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK\/SIRT1-independent pathway","volume":"60","author":"Kitada","year":"2011","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1681\/asn.2007010089","article-title":"Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet","volume":"18","author":"Kume","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-010-1703-y","article-title":"Additive effect of PPAR-\u03b3 agonist and ARB in treatment of experimental IgA nephropathy","volume":"26","author":"Lai","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: The forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1039\/c3fo60062a","article-title":"Monascin improves diabetes and dyslipidemia by regulating PPAR\u03b3 and inhibiting lipogenesis in fructose-rich diet-induced C57BL\/6 mice","volume":"4","author":"Lee","year":"2013","journal-title":"Food Funct."},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jnutbio.2018.03.016","article-title":"Tocotrienol-rich fraction supplementation reduces hyperglycemia-induced skeletal muscle damage through regulation of insulin signaling and oxidative stress in type 2 diabetic mice","volume":"57","author":"Lee","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","article-title":"PPAR\u03b3 and the global map of adipogenesis and beyond","volume":"25","author":"Lefterova","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"B39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbrc.2016.10.152","article-title":"Distinct functions of PPAR\u03b3 isoforms in regulating adipocyte plasticity","volume":"481","author":"Li","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1523-1755.2005.00151.x","article-title":"EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-\u03b3\u2013dependent mechanism","volume":"67","author":"Li","year":"2005","journal-title":"Kidney Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic nephropathy\u2013complications and treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3109\/0886022X.2015.1128236","article-title":"Supplementation with high-dose trans-resveratrol improves ultrafiltration in peritoneal dialysis patients: A prospective, randomized, double-blind study","volume":"38","author":"Lin","year":"2016","journal-title":"Ren. Fail."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3389\/fphys.2020.01050","article-title":"Dyslipidemia in kidney disorders: Perspectives on mitochondria homeostasis and therapeutic opportunities","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.biopha.2018.02.127","article-title":"Zhen-Wu-tang protects against podocyte injury in rats with IgA nephropathy via PPAR\u03b3\/NF-\u03baB pathway","volume":"101","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull. World Health Organ."},{"key":"B46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fendo.2018.00473","article-title":"Deciphering the roles of PPAR\u03b3 in adipocytes via dynamic change of transcription complex","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2917474","DOI":"10.1155\/2020\/2917474","article-title":"PPAR\u03b3 and its agonists in chronic kidney disease","volume":"2020","author":"Ma","year":"2020","journal-title":"Int. J. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1242\/dmm.009266","article-title":"Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model","volume":"5","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0142291","DOI":"10.1371\/journal.pone.0142291","article-title":"Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes","volume":"10","author":"Marcia-Fracia","year":"2015","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2010.509","article-title":"Glucose handling by the kidney","volume":"79","author":"Mather","year":"2011","journal-title":"Kidney Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/jn\/133.5.1238","article-title":"Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells","volume":"133","author":"Mezei","year":"2003","journal-title":"J. Nutr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jama.2013.8141","article-title":"Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety","volume":"310","author":"Mitka","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.kint.2020.07.030","article-title":"Outcomes of patients with end-stage kidney disease hospitalized with COVID-19","volume":"98","author":"Ng","year":"2020","journal-title":"Kidney Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2215\/CJN.08950621","article-title":"Curcumin therapy to treat vascular dysfunction in Children and young adults with ADPKD: A randomized Controlled trial","volume":"17","author":"Nowak","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom5010194","article-title":"Advanced glycation end products and oxidative stress in type 2 diabetes mellitus","volume":"5","author":"Nowotny","year":"2015","journal-title":"Biomolecules"},{"key":"B57","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/toxsci\/kfl180","article-title":"Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities","volume":"97","author":"Ong","year":"2007","journal-title":"Toxicol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"0162044","DOI":"10.1371\/journal.pone.0162044","article-title":"Underweight is an independent risk factor for renal function deterioration in patients with IgA nephropathy","volume":"11","author":"Ouyang","year":"2016","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/molecules24050923","article-title":"The role of tocotrienol in protecting against metabolic diseases","volume":"24","author":"Pang","year":"2019","journal-title":"Molecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-0922-9","article-title":"Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy","volume":"14","author":"Park","year":"2016","journal-title":"J. Transl. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"153663","DOI":"10.1016\/j.phymed.2021.153663","article-title":"Tinospora cordifolia activates PPAR\u03b3 pathway and mitigates glomerular and tubular cell injury in diabetic kidney disease","volume":"91","author":"Patial","year":"2021","journal-title":"Phytomedicine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ndt\/gfw320","article-title":"Peroxisome proliferator activating receptor-\u03b3 and the podocyte","volume":"32","author":"Platt","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"B63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","article-title":"IgA nephropathy: An interesting autoimmune kidney disease","volume":"361","author":"Rajasekaran","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cbi.2016.03.015","article-title":"Chrysin, a PPAR-\u03b3 agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation","volume":"250","author":"Rani","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1371758","DOI":"10.1155\/2019\/1371758","article-title":"Rosiglitazone, a ligand to PPAR\u03b3, improves blood pressure and vascular function through renin-angiotensin system regulation","volume":"2019","author":"S\u00e1nchez-Aguilar","year":"2019","journal-title":"PPAR Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.tips.2015.06.010","article-title":"Ligands for the nuclear peroxisome proliferator-activated receptor gamma","volume":"36","author":"Sauer","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.phymed.2017.09.018","article-title":"Iridoid glycosides fraction from Picrorhiza kurroa attenuates cyclophosphamide-induced renal toxicity and peripheral neuropathy via PPAR-\u03b3 mediated inhibition of inflammation and apoptosis","volume":"36","author":"Sharma","year":"2017","journal-title":"Phytomedicine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jss.2013.11.1088","article-title":"Explicit role of peroxisome proliferator\u2013activated receptor gamma in gallic acid\u2013mediated protection against ischemia-reperfusion\u2013induced acute kidney injury in rats","volume":"187","author":"Singh","year":"2014","journal-title":"J. Surg. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1507\/endocrj.K10E-281","article-title":"Effects of PPAR\u03b3 on hypertension, atherosclerosis, and chronic kidney disease","volume":"57","author":"Sugawara","year":"2010","journal-title":"Endocr. J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1159\/000443121","article-title":"Pioglitazone, a peroxisome proliferator-activated receptor x03B3; agonist, ameliorates chronic kidney disease by enhancing Antioxidative capacity and attenuating angiogenesis in the kidney of a 5\/6 Nephrectomized rat model","volume":"38","author":"Sun","year":"2016","journal-title":"Cell. Physiol. biochem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12929-017-0371-7","article-title":"Distribution of glucose transporters in renal diseases","volume":"24","author":"Szablewski","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/14728222.2017.1280467","article-title":"Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome","volume":"21","author":"Tan","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/cam4.1354","article-title":"Pioglitazone and bladder cancer risk: A systematic review and meta\u2010analysis","volume":"7","author":"Tang","year":"2018","journal-title":"Cancer Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5812\/nephropathol.7512","article-title":"Inhibition of gentamicin\u2013induced renal tubular cell necrosis","volume":"1","author":"Tavafi","year":"2012","journal-title":"J. Nephropathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"53796","DOI":"10.1371\/journal.pone.0053796","article-title":"Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1\/2-PPAR\u03b3-adiponectin pathway","volume":"8","author":"Tian","year":"2013","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ekir.2017.01.007","article-title":"The renal pathology of obesity","volume":"2","author":"Tsuboi","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B79","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.ackd.2010.10.003","article-title":"Hypertension in diabetic nephropathy: Epidemiology, mechanisms, and management","volume":"18","author":"Van Buren","year":"2011","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): A review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fphar.2019.00833","article-title":"Resveratrol protects against post-contrast acute kidney injury in rabbits with diabetic nephropathy","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1874312901206010103","article-title":"Regulation of matrix Remodeling by peroxisome proliferator-activated receptor-\u03b3: A novel link between metabolism and Fibrogenesis","volume":"6","author":"Wei","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20160780","article-title":"Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)\u2013salt-induced hypertension","volume":"131","author":"Wei","year":"2017","journal-title":"Clin. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1073\/pnas.1116971109","article-title":"Amorfrutins are potent antidiabetic dietary natural products","volume":"109","author":"Weidner","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00125-013-2920-2","article-title":"Amorfrutin B is an efficient natural peroxisome proliferator-activated receptor gamma (PPAR\u03b3) agonist with potent glucose-lowering properties","volume":"56","author":"Weidner","year":"2013","journal-title":"Diabetologia"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2054358118813088","DOI":"10.1177\/2054358118813088","article-title":"Micro-particle curcumin for the treatment of chronic kidney disease-1: Study protocol for a multicenter clinical trial","volume":"5","author":"Weir","year":"2018","journal-title":"Can. J. Kidney Health Dis."},{"key":"B88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41100-016-0021-7","article-title":"Global challenges posed by the growth of end-stage renal disease","volume":"2","author":"Wetmore","year":"2016","journal-title":"Ren. Replace. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"7298635","DOI":"10.1155\/2019\/7298635","article-title":"Biomarkers of acute kidney injury after cardiac surgery: A narrative review","volume":"2019","author":"Wu","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/ndt\/gfn746","article-title":"Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy","volume":"24","author":"Xiao","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"B91","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11418-019-01290-y","article-title":"B-ring-homo-tonghaosu, isolated from Chrysanthemum morifolium capitulum, acts as a peroxisome proliferator-activated receptor-\u03b3 agonist","volume":"73","author":"Zhang","year":"2019","journal-title":"J. Nat. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11892-005-0057-5","article-title":"PPAR-\u03b3 agonists and diabetic nephropathy","volume":"5","author":"Zhang","year":"2005","journal-title":"Curr. Diab. Rep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41401-019-0319-4","article-title":"Asiatic acid prevents renal fibrosis in UUO rats via promoting the production of 15d-PGJ2, an endogenous ligand of PPAR-\u03b3","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13148-021-01079-5","article-title":"Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: An epigenetic perspective","volume":"13","author":"Zheng","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"B96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0006-291X(02)00138-9","article-title":"Genetic analysis of four novel peroxisome proliferator activated receptor-\u03b3 splice variants in monkey macrophages","volume":"293","author":"Zhou","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1039\/C5FO01464F","article-title":"Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-l\u03b1 in rats","volume":"7","author":"Zhu","year":"2016","journal-title":"Food Funct."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.991059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T06:33:12Z","timestamp":1666333992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.991059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":95,"alternative-id":["10.3389\/fphar.2022.991059"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.991059","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"article-number":"991059"}}